Frail patients in the ibrutinib arms showed a trend toward improvement in each geriatric domain over time.
← all excerpts
The Five "Ws" of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When.
1
—
—
Frail patients in the ibrutinib arms showed a trend toward improvement in each geriatric domain over time.